Select Amino Acids Increased Anion Secretion in Primary F508del/F508del HBEC by Activating CFTR and Alternative Anion Secretory Pathways

被引：0
|
作者：
Grosche, A. [1 ]
Xu, X. [1 ]
Angoli, D. [2 ]
Guo, J. [1 ]
Prabhakaran, S. [3 ]
Vidyasagar, S. [1 ]
机构：
[1] Univ Florida, Radiat Oncol, Gainesville, FL 32611 USA
[2] Entrins Biosci, Norwood, MA USA
[3] Univ Florida, Gainesville, FL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1990
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ESTIMATING THE "AGE" OF THE F508DEL MUTATION WITH FAMILY STUDIES
    Farrell, P. M.
    Barton, D.
    Rogers, M.
    Frischer, T.
    Renner, S.
    Riss, K.
    Genin, E.
    Sahbatou, M.
    Rouault, K.
    Giteau, K.
    Ferec, C.
    PEDIATRIC PULMONOLOGY, 2010, : 289 - 289
  • [42] Unveiling the role of the mutation F508del in cystic fibrosis
    Abreu, B.
    Lopes, E.
    Sofia, A.
    Oliveira, F.
    Soares, C. M.
    FEBS JOURNAL, 2017, 284 : 307 - 307
  • [43] Rapid F508del and F508C assay using fluorescent hybridization probes
    Gundry, CN
    Bernard, PS
    Herrmann, MG
    Reed, GH
    Wittwer, CT
    GENETIC TESTING, 1999, 3 (04): : 365 - 370
  • [44] CHANGE IN BURDEN OF ILLNESS IN CF PATIENTS HOMOZYGOUS FOR THE F508DEL CFTR GENE MUTATION
    Lubarsky, B.
    O'Sullivan, A.
    Millar, S.
    Pasta, D.
    Sawicki, G.
    Wagener, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 346 - 347
  • [45] EFFECTS OF LUMACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS HOMOZYGOUS FOR F508DEL CFTR MUTATION
    Melotti, P.
    Tridello, G.
    Pintani, E.
    Meneghelli, I
    Volpi, S.
    Spinelli, E.
    D'Orazio, C.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 242 - 242
  • [46] CF BONE DISEASE: EFFECT OF CFTR CORRECTORS ON HUMAN OSTEOBLASTS WITH THE F508DEL MUTATION
    Velard, F.
    Delion, M.
    Guillaume, C.
    Tabary, O.
    Barthes, F.
    Touqui, L.
    Gangloff, S.
    Sermet-Gaudelus, I
    Jacquot, J.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 422 - 422
  • [47] Impact of lumacaf tor/ivacaf tor and tezacaf tor/ivacaf tor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis
    McElvaney, Oliver J.
    Heltshe, Sonya L.
    Odem-Davis, Katherine
    West, Natalie E.
    Sanders, Don B.
    Fogarty, Barbra
    VanDevanter, Donald R.
    Flume, Patrick A.
    Goss, Christopher H.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 875 - 879
  • [48] LEAD IDENTIFICATION OF CFTR F508DEL CORRECTORS THROUGH A COMBINATION OF FUNCTIONAL AND MECHANISTIC ASSAYS
    Liang, F.
    Harrington, J.
    Layer, E.
    Valdez, R.
    Bhatt, P.
    Amarnani, D.
    Sui, J.
    Cole, B.
    Bihler, H.
    Mense, M.
    Fitzpatrick, R.
    PEDIATRIC PULMONOLOGY, 2011, : 278 - 279
  • [49] SEVERE BONE LOSS ASSOCIATED WITH REDUCED BONE FORMATION IN F508DEL CFTR MICE
    Le Henaff, C.
    Gimenez, A.
    Hay, E.
    Marty, C.
    Marie, P.
    Jacquot, J.
    PEDIATRIC PULMONOLOGY, 2010, : 293 - 293
  • [50] Cystic fibrosis: scheme ELX/TEZ/IVA in children with F508del CFTR allele?
    Simon, Annika
    PNEUMOLOGIE, 2023, 77 (08):
12345